To dry or not too dry: should we be more tolerant of stable subretinal fluid in patients receiving anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration?

2015 ◽  
Vol 43 (8) ◽  
pp. 707-710 ◽  
Author(s):  
Hessom Razavi ◽  
Jennifer Arnold ◽  
Robyn Guymer
Sign in / Sign up

Export Citation Format

Share Document